Solitaire 2 和 Solitaire Platinum 重建装置
K号: K181060 · 2018-08-24
广告
决定日期2018-08-24
产品代码POL
咨询委员会NE
请注意，您提供的文本“NE”不足以进行翻译，因为它不是一个完整的句子或描述。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。
决定实质等同
器械摘要
Solitaire 2 and Solitaire Platinum Revascularization Device is the device name listed in this FDA 510(k) record. The listed applicant is Medtronic Neurovascular. It received FDA 510(k) clearance on 2018-08-24 under 510(k) number K181060. The device is classified under product code POL. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.
常见问题
What is the Solitaire 2 and Solitaire Platinum Revascularization Device?
Solitaire 2 and Solitaire Platinum Revascularization Device is a medical device that received FDA 510(k) clearance on 2018-08-24. The listed applicant is Medtronic Neurovascular. The 510(k) number is K181060.
When did Solitaire 2 and Solitaire Platinum Revascularization Device receive FDA 510(k) clearance?
Solitaire 2 and Solitaire Platinum Revascularization Device received FDA 510(k) clearance on 2018-08-24, under 510(k) number K181060.
Who is the listed applicant for Solitaire 2 and Solitaire Platinum Revascularization Device?
The FDA 510(k) record lists Medtronic Neurovascular as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Solitaire 2 and Solitaire Platinum Revascularization Device?
The FDA product code for Solitaire 2 and Solitaire Platinum Revascularization Device is POL.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
相关器械（代码：POL）
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告